These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33887514)

  • 1. D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial.
    Degiuli M; Reddavid R; Tomatis M; Ponti A; Morino M; Sasako M;
    Eur J Cancer; 2021 Jun; 150():10-22. PubMed ID: 33887514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer: Current status of lymph node dissection.
    Degiuli M; De Manzoni G; Di Leo A; D'Ugo D; Galasso E; Marrelli D; Petrioli R; Polom K; Roviello F; Santullo F; Morino M
    World J Gastroenterol; 2016 Mar; 22(10):2875-93. PubMed ID: 26973384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
    Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
    Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
    Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
    Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.
    Chen JH; Cai SR; Zhai ET; Chen SL; Wu KM; Song W; He YL
    Int J Clin Exp Pathol; 2015; 8(11):14365-73. PubMed ID: 26823752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of lymph node dissection for adenocarcinoma of the stomach.
    Mocellin S; McCulloch P; Kazi H; Gama-Rodrigues JJ; Yuan Y; Nitti D
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001964. PubMed ID: 26267122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.
    Verlato G; Giacopuzzi S; Bencivenga M; Morgagni P; De Manzoni G
    World J Gastroenterol; 2014 Sep; 20(36):12883-91. PubMed ID: 25278685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of lymphadenectomy in gastric cancer surgery.
    Symeonidis D; Diamantis A; Bompou E; Tepetes K
    J BUON; 2019; 24(5):1761-1767. PubMed ID: 31786835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of long-term prognosis of laparoscopy-assisted gastrectomy and conventional open gastrectomy with special reference to D2 lymph node dissection.
    Sato H; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Goto M; Kashihara H; Takasu C
    Surg Endosc; 2012 Aug; 26(8):2240-6. PubMed ID: 22311300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.
    Degiuli M; Sasako M; Ponti A; Calvo F
    Br J Cancer; 2004 May; 90(9):1727-32. PubMed ID: 15150592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
    Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery.
    Kung CH; Tsai JA; Lundell L; Johansson J; Nilsson M; Lindblad M
    BJS Open; 2020 Jun; 4(3):424-431. PubMed ID: 32129948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
    de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
    Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
    Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
    World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascularizing lymph node dissection for advanced gastric cancer: A single-institution experience.
    Han FH; Zhou SN; Li HM; He YL; Zhan WH
    World J Gastroenterol; 2016 Apr; 22(14):3813-20. PubMed ID: 27076766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching.
    Kang JH; Ryu SY; Jung MR; Jeong O
    Eur J Surg Oncol; 2020 Jul; 46(7):1239-1246. PubMed ID: 32331983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term and long-term risk factors in gastric cancer.
    Verlato G; Marrelli D; Accordini S; Bencivenga M; Di Leo A; Marchet A; Petrioli R; Zoppini G; Muggeo M; Roviello F; de Manzoni G
    World J Gastroenterol; 2015 Jun; 21(21):6434-43. PubMed ID: 26074682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.